Pfizer says Sutent fails to meet key goals in 2 late-stage breast …

‚ÄúSunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have helped us define the limits and opportunities for the compound and better understand the …. libbyshope How Breast Cancer Patients Want to Search for and Retrieve Information From Stories of Other Patients on the Internet: an Online Randomized Controlled Experiment | Overberg | Journal of Medical Internet Research …

Read more:
Pfizer says Sutent fails to meet key goals in 2 late-stage breast …

No comments yet.

TOP